DrugPatentWatch Database Preview
Aaa Usa Inc Company Profile
What is the competitive landscape for AAA USA INC, and when can generic versions of AAA USA INC drugs launch?
AAA USA INC has two approved drugs.
There is one US patent protecting AAA USA INC drugs.
There are twenty-one patent family members on AAA USA INC drugs in eighteen countries.
Summary for Aaa Usa Inc
| International Patents: | 21 |
| US Patents: | 1 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Aaa Usa Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aaa Usa Inc | NETSPOT | gallium dotatate ga-68 | POWDER;INTRAVENOUS | 208547-001 | Jun 1, 2016 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Aaa Usa Inc | LUTATHERA | lutetium dotatate lu-177 | SOLUTION;IV (INFUSION) | 208700-001 | Jan 26, 2018 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Aaa Usa Inc | LUTATHERA | lutetium dotatate lu-177 | SOLUTION;IV (INFUSION) | 208700-001 | Jan 26, 2018 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Aaa Usa Inc | NETSPOT | gallium dotatate ga-68 | POWDER;INTRAVENOUS | 208547-001 | Jun 1, 2016 | RX | Yes | Yes | 9,375,498 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Aaa Usa Inc | NETSPOT | gallium dotatate ga-68 | POWDER;INTRAVENOUS | 208547-001 | Jun 1, 2016 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Non-Orange Book US Patents for Aaa Usa Inc
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 9,907,868 | Process for the preparation of complexes of .sup.68Ga | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Aaa Usa Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 2955168 | ➤ Sign Up |
| Canada | 2844145 | ➤ Sign Up |
| Russian Federation | 2605090 | ➤ Sign Up |
| China | 103889930 | ➤ Sign Up |
| Japan | 2014524423 | ➤ Sign Up |
| European Patent Office | 2742017 | ➤ Sign Up |
| Israel | 230904 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.
